Acta Neuropathologica Communications (Jul 2022)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP

  • Sarah Pickles,
  • Tania F. Gendron,
  • Yuka Koike,
  • Mei Yue,
  • Yuping Song,
  • Jennifer M. Kachergus,
  • J. Shi,
  • Michael DeTure,
  • E. Aubrey Thompson,
  • Björn Oskarsson,
  • Neill R. Graff-Radford,
  • Bradley F. Boeve,
  • Ronald C. Petersen,
  • Zbigniew K. Wszolek,
  • Keith A. Josephs,
  • Dennis W. Dickson,
  • Leonard Petrucelli,
  • Casey N. Cook,
  • Mercedes Prudencio

DOI
https://doi.org/10.1186/s40478-022-01408-6
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) is a neurodegenerative disease primarily affecting the frontal and/or temporal cortices. However, a growing body of evidence suggests that the cerebellum contributes to biochemical, cognitive, and behavioral changes in FTLD-TDP. To evaluate cerebellar TDP-43 expression and function in FTLD-TDP, we analyzed TDP-43 protein levels and the splicing of a TDP-43 target, STMN2, in the cerebellum of 95 FTLD-TDP cases and 25 non-neurological disease controls. Soluble TDP-43 was decreased in the cerebellum of FTLD-TDP cases but a concomitant increase in insoluble TDP-43 was not seen. Truncated STMN2 transcripts, an indicator of TDP-43 dysfunction, were elevated in the cerebellum of FTLD-TDP cases and inversely associated with TDP-43 levels. Additionally, lower cerebellar TDP-43 associated with a younger age at disease onset. We provide evidence of TDP-43 loss of function in the cerebellum in FTLD-TDP, supporting further investigation into this understudied brain region.

Keywords